This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (2)  • Contact me when this article is cited  Related Content  • Related articles  • Similar articles in this journal

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

As a geriatrician, I enjoyed reading the report of Brass et al¹ on the underuse of warfarin sodium treatment in the elderly, even in the best candidates for that type of treatment. In a previous report,² I also analyzed reports of underuse in an effort to find an explanation for this unfortunate phenomenon. I, however, came to a different conclusion.

The authors appear to be perplexed and puzzled, offering many possible explanations. Although the problem could be multifactorial, I believe the major reason for the undertreatment is the medical neglect toward the elderly, which has been well documented during the past 20 years. Butler³ described the situation well in his Pulitzer Prize–winning publication Why Survive? Being Old in America. One would hope that the emergence of geriatric medicine within internal and family medicine would sensitize the general medical practitioners to the specific needs of the elderly and the proper means . . . [Full Text of this Article]

RELATED ARTICLES

Warfarin Use Following Ischemic Stroke Among Medicare Patients With Atrial Fibrillation
Lawrence M. Brass, Harlan M. Krumholz, Jeanne D. Scinto, Deepak Mathur, and Martha Radford
Arch Intern Med. 1998;158(19):2093-2100.
ABSTRACT | FULL TEXT  

Comparison of an Anticoagulation Clinic With Usual Medical Care: Anticoagulation Control, Patient Outcomes, and Health Care Costs
Elaine Chiquette, Mary G. Amato, and Henry I. Bussey
Arch Intern Med. 1998;158(15):1641-1647.
ABSTRACT | FULL TEXT  

Atrial fibrillation and stroke prevention with warfarin in the long-term care setting
J. H. Gurwitz, J. Monette, P. A. Rochon, M. A. Eckler, and J. Avorn
Arch Intern Med. 1997;157(9):978-984.
ABSTRACT  

Warfarin for atrial fibrillation. The patient's perspective
M. Man-Son-Hing, A. Laupacis, A. O'Connor, G. Wells, J. Lemelin, W. Wood, and M. Dermer
Arch Intern Med. 1996;156(16):1841-1848.
ABSTRACT  

Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials
Arch Intern Med. 1994;154(13):1449-1457.
ABSTRACT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Safety of Anticoagulation Therapy in Well-informed Older Patients
Kagansky et al.
Arch Intern Med 2004;164:2044-2050.
ABSTRACT | FULL TEXT